Celltrion Approvals Set Up Denosumab Showdown In US

Korean Firm Wins FDA Nod For Third Prolia And Xgeva Biosimilars

 
• By Dave Wallace
  
Three approved denosumab biosimilars are preparing to face off in the US (Shutterstock)

More from Biosimilars

More from Business